HC Wainwright Reaffirms Buy Rating for Quantum-Si (NASDAQ:QSI)

HC Wainwright reaffirmed their buy rating on shares of Quantum-Si (NASDAQ:QSI) in a research report sent to investors on Wednesday,Benzinga reports. The brokerage currently has a $4.00 price objective on the stock.

Separately, Canaccord Genuity Group dropped their target price on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday.

Quantum-Si Stock Performance

Shares of QSI opened at $0.73 on Wednesday. The stock has a fifty day moving average price of $0.85 and a two-hundred day moving average price of $1.10. Quantum-Si has a 52-week low of $0.70 and a 52-week high of $2.43. The company has a market cap of $104.54 million, a price-to-earnings ratio of -1.15 and a beta of 2.89.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. XTX Topco Ltd bought a new position in Quantum-Si during the second quarter worth about $25,000. Public Employees Retirement System of Ohio acquired a new position in shares of Quantum-Si during the first quarter worth about $27,000. Bleakley Financial Group LLC acquired a new position in shares of Quantum-Si during the first quarter worth about $28,000. SG Americas Securities LLC bought a new position in shares of Quantum-Si during the third quarter worth about $53,000. Finally, Virtu Financial LLC acquired a new stake in Quantum-Si in the 1st quarter valued at approximately $98,000. Institutional investors and hedge funds own 39.90% of the company’s stock.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.